111960-11-3Relevant articles and documents
POLY-ADP RIBOSE POLYMERASE (PARP) INHIBITORS
-
Page/Page column 90; 91, (2018/07/29)
The present invention is related to a pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and a compound represented by the following structural formula: The present invention is also related a method of treating a subject with a disease which can be ameliorated by inhibition of poly(ADP-ribose)polymerase (PARP). The definitions of the variables are provided herein.